Premium
Patient‐centered appraisal of race‐free clinical risk assessment
Author(s) -
Manski Charles F.
Publication year - 2022
Publication title -
health economics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.55
H-Index - 109
eISSN - 1099-1050
pISSN - 1057-9230
DOI - 10.1002/hec.4569
Subject(s) - race (biology) , harm , risk assessment , health care , medicine , actuarial science , affect (linguistics) , psychology , social psychology , business , political science , economics , sociology , gender studies , management , communication , law
Until recently, there has been a consensus that clinicians seeking to assess patient risks of illness should condition risk assessments on all observed patient covariates with predictive power. The broad idea is that knowing more about patients enables more accurate predictions of their health risks and, hence, better clinical decisions. This consensus has recently unraveled with respect to a specific covariate, namely race. There have been increasing calls for race‐free risk assessment, arguing that using race to predict health risks contributes to racial disparities and inequities in health care. In some medical fields, leading institutions have recommended race‐free risk assessment. An important open question is how race‐free risk assessment would affect the quality of clinical decisions. Considering the matter from the patient‐centered perspective of medical economics yields a disturbing conclusion: Race‐free risk assessment would harm patients of all races.